CN106668018A - 一种右兰索拉唑钠的缓释胶囊及其制备方法 - Google Patents
一种右兰索拉唑钠的缓释胶囊及其制备方法 Download PDFInfo
- Publication number
- CN106668018A CN106668018A CN201611241491.4A CN201611241491A CN106668018A CN 106668018 A CN106668018 A CN 106668018A CN 201611241491 A CN201611241491 A CN 201611241491A CN 106668018 A CN106668018 A CN 106668018A
- Authority
- CN
- China
- Prior art keywords
- enteric
- parts
- capsule
- coating
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611241491.4A CN106668018B (zh) | 2016-12-29 | 2016-12-29 | 一种右兰索拉唑钠的缓释胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611241491.4A CN106668018B (zh) | 2016-12-29 | 2016-12-29 | 一种右兰索拉唑钠的缓释胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106668018A true CN106668018A (zh) | 2017-05-17 |
CN106668018B CN106668018B (zh) | 2019-12-06 |
Family
ID=58872307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611241491.4A Active CN106668018B (zh) | 2016-12-29 | 2016-12-29 | 一种右兰索拉唑钠的缓释胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106668018B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011121548A1 (en) * | 2010-03-31 | 2011-10-06 | Ranbaxy Laboratories Limited | Process for the preparation of dexlansoprazole |
WO2012095859A1 (en) * | 2011-01-12 | 2012-07-19 | Hetero Research Foundation | Polymorphs of dexlansoprazole salts |
CN105017218A (zh) * | 2015-07-01 | 2015-11-04 | 合肥安德生制药有限公司 | 一种右兰索拉唑晶型及其制备方法 |
-
2016
- 2016-12-29 CN CN201611241491.4A patent/CN106668018B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011121548A1 (en) * | 2010-03-31 | 2011-10-06 | Ranbaxy Laboratories Limited | Process for the preparation of dexlansoprazole |
WO2012095859A1 (en) * | 2011-01-12 | 2012-07-19 | Hetero Research Foundation | Polymorphs of dexlansoprazole salts |
CN105017218A (zh) * | 2015-07-01 | 2015-11-04 | 合肥安德生制药有限公司 | 一种右兰索拉唑晶型及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106668018B (zh) | 2019-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1562573B1 (en) | Pharmaceutical pellets comprising tamsulosin and a process for making the same | |
US20050095293A1 (en) | Administration form for the oral application of poorly soluble drugs | |
BG64967B1 (bg) | Метод за получаване на орален фармацевтичен препарат, включващ съединение с противоязвена активност | |
JP2002523443A (ja) | オメプラゾール製剤 | |
CN1886119A (zh) | 泮托拉唑多颗粒制剂 | |
JP2020534246A (ja) | 重水素化ドンペリドン組成物、方法、及び調製 | |
WO2010072105A1 (zh) | 一种度洛西汀肠溶制剂及其芯材和制备方法 | |
JP5479909B2 (ja) | 新規製剤 | |
CN101513403A (zh) | 含有苯并咪唑类化合物的药物制剂 | |
WO2021238978A1 (zh) | 含硝羟喹啉前药的药物组合物及其制备方法和应用 | |
CN103356489B (zh) | 一种质子泵抑制剂肠溶微丸及其制剂、制备方法 | |
CN106619520B (zh) | 一种右兰索拉唑钠的干混悬剂及其制备方法 | |
CN1210065C (zh) | 具有改善溶出性能的普仑司特的固体分散体系及其制备方法 | |
EP2050436A1 (en) | Pharmaceutical composition containing dutasteride | |
EP2359814A1 (en) | Pharmaceutical mini-tablets for sustained release of flecainide acetate | |
WO2012040082A2 (en) | Antidiabetic solid pharmaceutical compositions | |
CN105326801B (zh) | 一种埃索美拉唑肠溶包衣液的配制工艺及使用方法 | |
US20060063832A1 (en) | Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof | |
CN106668018A (zh) | 一种右兰索拉唑钠的缓释胶囊及其制备方法 | |
CN105764509B (zh) | 达比加群酯或其盐的投药制剂及其制备方法 | |
CN106727381B (zh) | 一种右兰索拉唑钠的口崩片及其制备方法 | |
EP1594479A1 (en) | Stable oral benzimidazole compositions and processes for their preparation | |
CA3160834A1 (en) | Amorphous pharmaceutical compositions of abiraterone acetate | |
PT2001445E (pt) | Esferoides farmacêuticos | |
KR101296328B1 (ko) | 피브레이트계 약물을 포함하는 고체분산체 및 이의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 210061 122, Hua Kang Road, hi tech Development Zone, Nanjing, Jiangsu. Applicant after: NANJING HAIRONG PHARMACEUTICAL CO., LTD. Applicant after: Chengdu Dikang pharmaceutical Limited by Share Ltd Address before: 210061 122, Hua Kang Road, hi tech Development Zone, Nanjing, Jiangsu. Applicant before: NANJING HAIRONG PHARMACEUTICAL CO., LTD. Applicant before: Chengdu Dikang Pharmaceutical Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20170517 Assignee: Chongqing Dikang Changjiang Pharmaceutical Co.,Ltd. Assignor: NANJING HAIRONG PHARMACEUTICAL Co.,Ltd.|Chengdu Di Kang medicine companies LLC Contract record no.: X2021510000035 Denomination of invention: The invention relates to a sustained-release capsule of right lansoprazole sodium and a preparation method thereof Granted publication date: 20191206 License type: Common License Record date: 20210916 |